Real-world prospective data confirms improved risk stratification in multiple myeloma using SKY92 gene expression profiling
ROTTERDAM, Netherlands and SAN DIEGO, June 12, 2025, 02:00 GMT-04
SKYLINEDX-myeloma
Read full article →This category brings together content related to healthcare, medicine, clinical research, healthcare services, medical devices, therapies and the development of solutions for the sector. Sector classification by EMSF Lisboa.
ROTTERDAM, Netherlands and SAN DIEGO, June 12, 2025, 02:00 GMT-04
SKYLINEDX-myeloma
Read full article →
LAS VEGAS, June 11, 2025, 17:31 GMT-04
DelveInsight-Business
Read full article →
PUNE, India, June 11, 2025, 13:04 GMT-04
Credence-Research
Read full article →
CHICAGO, June 11, 2025, 10:48 GMT-04
THE-RESEARCH-INSIGHTS
Read full article →
DELRAY BEACH, Fla., June 11, 2025, 10:15 GMT-04
MarketsandMarkets
Read full article →
SAN ANTONIO, June 11, 2025, 10:00 GMT-04
Frost-&-Sullivan
Read full article →
HONG KONG and SHANGHAI, June 11, 2025, 07:46 GMT-04
PingAn-GoodDr-Launch
Read full article →
COPENHAGEN, Denmark, June 11, 2025, 07:00 GMT-04
Corti
Read full article →
STOCKHOLM, June 11, 2025, 04:08 GMT-04
EQT-SpliceBio
Read full article →
BARCELONA, Spain, June 11, 2025, 03:00 GMT-04
SpliceBio-Funding
Read full article →
LAS VEGAS, June 10, 2025, 17:31 GMT-04
DelveInsight-Business
Read full article →
BOSTON, June 10, 2025, 13:09 GMT-04
BCC-Research-LLC
Read full article →
VANCOUVER, BC, June 10, 2025, 11:17 GMT-04
Equity-Insider-Health
Read full article →
DELRAY BEACH, Fla., June 10, 2025, 10:15 GMT-04
MnM-Exosome
Read full article →
NEWBURY, England, June 10, 2025, 09:50 GMT-04
Ortho-Consulting-Grou
Read full article →
SAN ANTONIO, June 10, 2025, 09:00 GMT-04
Frost-&-Sullivan
Read full article →
COPENHAGEN, Denmark, June 10, 2025, 07:00 GMT-04
Adcendo-ADCE-D01
Read full article →
NAIROBI, Kenya, June 10, 2025, 05:17 GMT-04
NCCN
Read full article →
CHICAGO, June 10, 2025, 04:00 GMT-04
ISHRS-New-Survey
Read full article →
BOSTON and LAUSANNE, Switzerland, June 10, 2025, 03:30 GMT-04
Alys-Pharmaceuticals
Read full article →